Chen Long, Ding Mei-Lin, Wu Fang, He Wen, Li Jin, Zhang Xiao-Yu, Xie Wen-Li, Duan Sheng-Zhong, Xia Wen-Hao, Tao Jun
From the Department of Hypertension and Vascular Disease (L.C., F.W., X.-Y.Z., W.-L.X., W.-H.X., J.T.), Department of Geriatrics (L.C., M.-L.D., F.W., W.H., J.L., J.T.), the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Shanghai, China (S.-Z.D.).
Hypertension. 2016 Feb;67(2):430-9. doi: 10.1161/HYPERTENSIONAHA.115.06597. Epub 2015 Nov 30.
Although hyperaldosteronemia exerts detrimental impacts on vascular endothelium in addition to elevating blood pressure, the effects and molecular mechanisms of hyperaldosteronemia on early endothelial progenitor cell (EPC)-mediated endothelial repair after arterial damage are yet to be determined. The aim of this study was to investigate the endothelial repair capacity of early EPCs from hypertensive patients with primary hyperaldosteronemia (PHA). In vivo endothelial repair capacity of early EPCs from PHAs (n=20), age- and blood pressure-matched essential hypertension patients (n=20), and age-matched healthy subjects (n=20) was evaluated by transplantation into a nude mouse carotid endothelial denudation model. Endothelial function was evaluated by flow-mediated dilation of brachial artery in human subjects. In vivo endothelial repair capacity of early EPCs and flow-mediated dilation were impaired both in PHAs and in essential hypertension patients when compared with age-matched healthy subjects; however, the early EPC in vivo endothelial repair capacity and flow-mediated dilation of PHAs were impaired more severely than essential hypertension patients. Oral spironolactone improved early EPC in vivo endothelial repair capacity and flow-mediated dilation of PHAs. Increased oxidative stress, oxidative 5,6,7,8-tetrahydrobiopterin degradation, endothelial nitric oxide synthase uncoupling and decreased nitric oxide production were found in early EPCs from PHAs. Nicotinamide adenine dinucleotide phosphate oxidase subunit p47(phox) knockdown or 5,6,7,8-tetrahydrobiopterin supplementation attenuated endothelial nitric oxide synthase uncoupling and enhanced in vivo endothelial repair capacity of early EPCs from PHAs. In conclusion, PHAs exhibited more impaired endothelial repair capacity of early EPCs than did essential hypertension patients independent of blood pressure, which was associated with mineralocorticoid receptor-dependent oxidative stress and subsequently 5,6,7,8-tetrahydrobiopterin degradation and endothelial nitric oxide synthase uncoupling.
尽管醛固酮增多症除了会升高血压外,还会对血管内皮产生有害影响,但醛固酮增多症对动脉损伤后早期内皮祖细胞(EPC)介导的内皮修复的影响及分子机制尚未明确。本研究旨在探讨原发性醛固酮增多症(PHA)高血压患者早期EPC的内皮修复能力。通过将来自PHA患者(n = 20)、年龄和血压匹配的原发性高血压患者(n = 20)以及年龄匹配的健康受试者(n = 20)的早期EPC移植到裸鼠颈动脉内皮剥脱模型中,评估其体内内皮修复能力。通过检测人体肱动脉血流介导的血管舒张功能来评估内皮功能。与年龄匹配的健康受试者相比,PHA患者和原发性高血压患者的早期EPC体内内皮修复能力和血流介导的血管舒张功能均受损;然而,PHA患者的早期EPC体内内皮修复能力和血流介导的血管舒张功能受损比原发性高血压患者更严重。口服螺内酯可改善PHA患者早期EPC的体内内皮修复能力和血流介导的血管舒张功能。在PHA患者的早期EPC中发现氧化应激增加、氧化型5,6,7,8 - 四氢生物蝶呤降解、内皮型一氧化氮合酶解偶联以及一氧化氮生成减少。敲低烟酰胺腺嘌呤二核苷酸磷酸氧化酶亚基p47(phox)或补充5,6,7,8 - 四氢生物蝶呤可减轻内皮型一氧化氮合酶解偶联,并增强PHA患者早期EPC的体内内皮修复能力。总之,与血压无关,PHA患者早期EPC的内皮修复能力受损比原发性高血压患者更严重,这与盐皮质激素受体依赖性氧化应激以及随后的5,6,7,8 - 四氢生物蝶呤降解和内皮型一氧化氮合酶解偶联有关。